Related Experiment Video
Updated: Jun 21, 2026

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
Published on: October 12, 2017
Pseudodistal ureteral stone resulting from calcified Deflux implantation
Anthony J Polcari1, Dae Y Kim, Brian T Helfand
1Department of Pediatric Urology, Children's Memorial Hospital, Chicago, IL 60614, USA.
Insights
Subureteral endoscopic injection of dextranomer/hyaluronic acid (Deflux) can cause microcalcification in the bladder wall. This calcified implant was mistaken for a ureteral stone in a pediatric patient presenting with abdominal pain.
Area of Science:
- Pediatric Urology
- Minimally Invasive Surgery
- Biomaterials Science
Background:
- Vesicoureteral reflux (VUR) affects 1% of pediatric patients.
- Subureteral endoscopic injection of dextranomer/hyaluronic acid (Deflux) is a popular minimally invasive VUR treatment.
- Histologic studies indicate Deflux implants may develop microcalcification.
Observation:
- A 12-year-old girl with VUR treated with Deflux presented with abdominal pain.
- Imaging revealed a hyperdense bladder wall mass, initially suspected as a distal ureteral stone.
- Cystoscopy and retrograde pyelography confirmed the mass was an intramural Deflux deposit.
Findings:
- This case highlights the potential for calcified Deflux implants to mimic ureteral stones on imaging.
- It is the second reported instance of this diagnostic confusion in a symptomatic patient.
- Microcalcification of Deflux implants is an identified, albeit infrequent, complication.
Implications:
- Radiologists and urologists should consider calcified Deflux implants in the differential diagnosis of bladder wall masses in patients with a history of VUR treatment.
- Accurate diagnosis prevents unnecessary invasive procedures for suspected ureteral stones.
- Further research into the long-term behavior and imaging characteristics of Deflux implants is warranted.
Abstract:
Vesicoureteral reflux (VUR) is a common clinical problem affecting 1% of pediatric patients. Subureteral endoscopic injection of dextranomer/hyaluronic acid (Deflux) is a minimally invasive treatment option for VUR that is rapidly gaining popularity. Histologic studies have demonstrated that in a minority of patients, the Deflux injection site can be associated with microcalcification. We report the case of a 12-year-old girl with a history of VUR who had previously been treated with Deflux and presented with abdominal pain and was noted to have a small hyperdense mass in the bladder wall on imaging. The presumptive diagnosis of a distal ureteral stone was ultimately ruled out by cystoscopy and retrograde pyelography, which revealed that the lesion seen on imaging represented the intramural Deflux deposit. This is the second reported case in which a calcified Deflux implant was mistaken for a distal ureteral stone in a patient presenting with abdominal pain.
Related Concept Videos
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi V: Nursing Management
Urinary Tract Calculi III: Medical Management
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
